CareView Communications Inc: extends loan maturity to Dec 31, 2026

What happened

• CareView Communications, Inc. filed an 8-K reporting that, as of Sep 30, 2026, the company, its wholly owned subsidiary CareView Communications, Inc. (the Borrower), PDL Investment Holdings, LLC (as assignee of PDL BioPharma, Inc.) in its capacity as administrative agent and lender, Steven G. Johnson, President and Chief Executive Officer, and Dr. James R. Higgins, a director, entered into a 16th Amendment to the Credit Agreement.
• The parties agreed to amend the Credit Agreement to provide that the maturity date shall be extended to Dec 31, 2026.

Key details

• Amendment executed as of Sep 30, 2026 and reported in the Current Report on Form 8-K filed Oct 6, 2026.
• The amendment is described as the 16th Amendment to the Credit Agreement between the company, the Borrower and PDL Investment Holdings, LLC (as administrative agent and lender).
• The amendment provides that the Maturity Date is extended to Dec 31, 2026.

Why it may matter

• The filing reports Item 1.01 (entry into a material definitive agreement) and Item 2.03 (creation of a direct financial obligation). Item 1.01 covers the 16th Amendment to the Credit Agreement that extends the maturity date; Item 2.03 reflects the related direct financial obligation.
• A filing does not show why the insider traded or why the company acted.